Patents by Inventor Toshiyuki Wakimoto

Toshiyuki Wakimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND, MANUFACTURING METHOD THEREFOR, ANTIMICROBIAL AGENT, AND MEDICINAL DRUG
    Publication number: 20240158341
    Abstract: A compound represented by Formula (1), Formula (2), or Formula (3), or a salt thereof, or a solvate thereof: wherein R1, R2, and R3 are the same or different and each represent a hydrazine group, an N-hydroxy-acetylamino group, or an N-hydroxy-formylamino group.
    Type: Application
    Filed: December 26, 2023
    Publication date: May 16, 2024
    Inventors: Masachika TAKATA, Hirofumi SUNAHARA, Toshiyuki WAKIMOTO, Kenichi MATSUDA
  • COPPER CHELATOR, ANTICANCER AGENT AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR WILSON'S DISEASE
    Publication number: 20240139144
    Abstract: A copper chelating agent that contains at least one compound selected from the group consisting of a compound represented by Formula (1), a compound represented by Formula (2), a compound represented by Formula (3), a compound represented by Formula (4), a salt thereof, and a solvate thereof:
    Type: Application
    Filed: December 26, 2023
    Publication date: May 2, 2024
    Inventors: Masachika TAKATA, Hirofumi SUNAHARA, Toshiyuki WAKIMOTO, Kenichi MATSUDA
  • PEPTIDE MACROCYCLIZATION ENZYME
    Publication number: 20210139917
    Abstract: A peptide cyclase that has the amino acid sequence represented by SEQ ID NO: 1 or a mutated sequence thereof, or a peptide cyclase that has an amino acid sequence encoded by a base sequence encoding the amino acid sequence represented by SEQ ID NO: 1 or a mutated sequence thereof; DNA encoding the peptide cyclase; a method for producing the peptide cyclase; and a method for producing a cyclic peptide using the peptide cyclase.
    Type: Application
    Filed: April 25, 2019
    Publication date: May 13, 2021
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Toshiyuki WAKIMOTO, Takefumi KURANAGA, Kenichi MATSUDA
  • Compound, ?adrenergic receptor antagonistic agent, and composition
    Patent number: 8110601
    Abstract: A novel compound, a novel ?1 adrenergic receptor antagonistic agent, and a novel composition are provided which are capable of exerting a therapeutic effect on treatment of hypertension as well as treatment of prostatic hypertrophy and the like.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: February 7, 2012
    Assignee: Suntory Holdings Limited
    Inventors: Toshiyuki Wakimoto, Haruo Nukaya, Yoshihide Suwa, Yoshiaki Yokoo
  • COMPOUND, Alpha1 ADRENERGIC RECEPTOR ANTAGONISTIC AGENT, AND COMPOSITION
    Publication number: 20100004328
    Abstract: A novel compound, a novel ?1 adrenergic receptor antagonistic agent, and a novel composition are provided which are capable of exerting a therapeutic effect on treatment of hypertension as well as treatment of prostatic hypertrophy and the like.
    Type: Application
    Filed: January 22, 2008
    Publication date: January 7, 2010
    Applicant: SUNTORY HOLDING LIMITED
    Inventors: Toshiyuki Wakimoto, Haruo Nukaya, Yoshihide Suwa, Yoshiaki Yokoo